⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4397549 | 0.96 | — | — | |
| SCHEMBL27468149 | 0.67 | — | — | |
| SCHEMBL13858763 | 0.65 | — | — | |
| SCHEMBL696205 | 0.59 | — | — | |
| SCHEMBL21331736 | 0.58 | — | — | |
| SCHEMBL8738119 | 0.56 | — | — | |
| SCHEMBL5707703 | 0.52 | — | — | |
| SCHEMBL2166227 | 0.50 | — | — | |
| SCHEMBL2166234 | 0.50 | — | — | |
| SCHEMBL669547 | 0.49 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106456806-B | Dual-purpose PAT/ultrasound contrast agent combined with drug-containing nanoparticles and preparation method thereof | 艾姆戈特株式会社 | 2023-02-17 | — | — | CN | disclosed |
| EP-4110277-A1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS | Symrise AG (DE) | 2023-01-04 | — | — | EP | disclosed |
| EP-4110477-A1 | COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ANTIOXIDANTS | Symrise AG (DE) | 2023-01-04 | — | — | EP | disclosed |
| WO-2022122896-A1 | COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ANTIOXIDANTS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | disclosed |
| WO-2022122943-A1 | COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS | SYMRISE AG (DE) | 2022-06-16 | — | — | WO | disclosed |
| CN-114425045-A | Nano-carrier acting on plasmodium in erythrocytic stage, preparation and preparation method thereof | 山西医科大学 | 2022-05-03 | — | — | CN | disclosed |
| CN-114302878-A | Tyrosine kinase non-receptor 1(TNK1) inhibitors and uses thereof | 大日本住友制药肿瘤公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-111518844-B | Preparation method of nano-selenium | 武汉轻工大学 | 2022-02-08 | — | — | CN | disclosed |
| CN-113853374-A | Compound forms and formulations thereof with enhanced bioavailability | PTC医疗公司 | 2021-12-28 | — | — | CN | disclosed |
| CN-113382738-A | Skin treatment methods and compositions for transdermal delivery of active agents | 塔普克斯制药公司 | 2021-09-10 | — | — | CN | disclosed |
| EP-2056782-A1 | USE OF CHROMEN-4-ONE DERIVATIVES | Merck Patent GmbH (DE) | 2009-05-13 | — | — | EP | disclosed |
| WO-2009016537-A2 | CONTINUOUS SPRAY SUNSCREEN COMPOSITIONS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008025368-A1 | USE OF CHROMEN-4-ONE DERIVATIVES | MERCK PATENT GMBH (DE) | 2008-03-06 | — | — | WO | disclosed |
| WO-2007122251-A2 | SYNERGISTIC MIXTURE OF GLYCOSYL FLAVANONES AND XANTHINES | SYMRISE GMBH & CO. KG (DE) | 2007-11-01 | — | — | WO | disclosed |
| CN-101060837-A | Preparation containing oxidized flavonoid derivatives | MERCK PATENT GMBH (DE) | 2007-10-24 | — | — | CN | disclosed |
| EP-1807039-A1 | USE OF GLYCOSYLATED FLAVANONES FOR THE BROWNING OF SKIN OR HAIR | Symrise GmbH & Co. KG (DE) | 2007-07-18 | — | — | EP | disclosed |
| EP-1802272-A1 | PROCESS FOR STRENGTHENING THE BARRIER FUNCTION OF UNDAMAGED SKIN | Symrise GmbH & Co. KG (DE) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006045760-A1 | USE OF GLYCOSYLATED FLAVANONES FOR THE BROWNING OF SKIN OR HAIR | SYMRISE GMBH & CO. KG (DE) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006040349-A1 | PROCESS FOR STRENGTHENING THE BARRIER FUNCTION OF UNDAMAGED SKIN | SYMRISE GMBH & CO. KG (DE) | 2006-04-20 | — | — | WO | disclosed |
| CN-1335309-A | New eka-favone and its application in preparation of cosmetic and dermatology | BASF AG (DE) | 2002-02-13 | — | — | CN | disclosed |